Home
Piramal Pharma Ltd Share Price History
Piramal Pharma Ltd
NSE : 24 Apr, 2025
219.87-3.8 (-1.7%)
Prev Close
223.6
Open Price
224.1
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
2475855
Today's High / Low
228.1 / 219.5
52 WK High / Low
307.9 / 136.1
Market Price of Piramal Pharma Ltd
1M
1Y
3Y
5Y
Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2021 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 8.4 |
| YoY Gr. | - |
| Net Profit (Cr.) | 835 |
| BVPS | 56.35 |
Key Financial Parameters
| Parameter | 2021 |
|---|---|
| Return on Capital Emp. % | 12.67 |
| Op. Profit Mgn % | 26.25 |
| Net Profit Mgn % | 13.22 |
| Debt to Equity % | 0.54 |
Latest Shareholding
Promoters Holdings Over Time
About Piramal Pharma Ltd
- Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
- It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
- In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. Piramal Pharma Solution provides integrated drug discovery, development, and manufacturing services for both drug substances, i.e. active pharmaceutical ingredients (APIs) and drug products, i.e. formulations across the life cycle of a molecule, from discovery and clinical development to commercial launch.
Popular Search
FAQs for Piramal Pharma Ltd Share Price History
What are the key events that typically impact Piramal Pharma Ltd's share price history?
Key events that impact Piramal Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Piramal Pharma Ltd's share price history?
Stock splits reduce the nominal price of Piramal Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Piramal Pharma Ltd?
Dividends can influence Piramal Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Piramal Pharma Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Piramal Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Piramal Pharma Ltd’s share price history?
To understand Piramal Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
